Omixon and AGBL Partner for Extensive Middle East and North-Africa Distribution Deal

29/11/2018

Omixon and Alliance Global FZ-LLC are pleased to announce the execution of an exclusive distribution agreement to cover markets in the Middle East, Africa and Central Asia. The partnership builds on Omixon’s existing customer base in some of the covered markets including Saudi Arabia and Kuwait. AGBL will further...

EFI Regional Meeting, January 26, 2019

15/11/2018

The Omixon Team is back in Bucharest, Romania for the upcoming Annual EFI Region 8 & Balkan EPT Meeting! Learn more about the EFI Meetings here…

Crabs, Epitopes and Revolutionary Products – the Highlights of ASHI 2018

25/10/2018

Thank you everyone for visiting us and joining our events during the 44th Annual ASHI Meeting. The Omixon Team – Efi, Maggi, Ellia, Renata, Nora, Kriszta, Pete, Dan, Gergo and Attila – went on a trip to Baltimore, Maryland, the home of crab cakes, a stunning harbor and lots...

Automated NGS-based HLA Typing and Epitope Matching at the 44th ASHI Annual Meeting 2018

27/09/2018

Omixon announce today that Holotype HLA and other Omixon products will be featured among nine posters produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s Lunch Symposium on Thursday 10/4 will focus on the importance...

Omixon & PIRCHE® collaborate on Epitope Determination with NGS

17/09/2018

Global molecular diagnostics company Omixon, headquartered in Budapest, and technology company PIRCHE AG, headquartered in Berlin announce a collaboration to deliver the first integrated epitope determination and matching service that leverages whole gene consensus sequences assembled from NGS data of the HLA region. For the first time, fully characterized...